
Join to View Full Profile
400 Parnassus AveSan Francisco, CA 94143
Dr. Ho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2021 - 2024
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2017 - 2020
- Ohio State University College of MedicineClass of 2017
- Duke UniversityBA, Computer Science, 2008 - 2012
Certifications & Licensure
- CA State Medical License 2024 - 2026
- WA State Medical License 2022 - 2025
- PA State Medical License 2017 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsReal-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal Antibody.Karthik Ramasamy, Ravi Vij, David Kuter, David Cella, Brian G M Durie
Clinical Lymphoma, Myeloma & Leukemia. 2025-05-01 - 1 citationsOutcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.Adam S Kittai, Ying Huang, Sarah Miller, John N Allan, Seema A Bhat
Blood Cancer Journal. 2025-02-20 - A phase 2 study of frontline pembrolizumab in follicular lymphoma.Carrie Ho, Songli Zhu, Ted Gooley, Taranjit S Gujral, Ryan C Lynch
Ejhaem. 2024-12-01
Press Mentions
- Fred Hutch at ASCO: New Insights on Financial Toxicity, Combination Therapies for Cancer and the Need for Targeted Breast Cancer Therapies in UgandaMay 26th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: